{'52WeekChange': 0.79431283,
 'SandP52WeekChange': 0.0644362,
 'address1': '6230 Stoneridge Mall Road',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 94.68,
 'askSize': 1000,
 'averageDailyVolume10Day': 604487,
 'averageVolume': 861195,
 'averageVolume10days': 604487,
 'beta': None,
 'beta3Year': None,
 'bid': 94.55,
 'bidSize': 1300,
 'bookValue': 4.385,
 'category': None,
 'circulatingSupply': None,
 'city': 'Pleasanton',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 95.76,
 'dayLow': 93.14,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -783.102,
 'enterpriseToRevenue': 34.051,
 'enterpriseValue': 8997062656,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 88.74057,
 'fiftyTwoWeekHigh': 108.359,
 'fiftyTwoWeekLow': 45.11,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 48925758,
 'forwardEps': -0.47,
 'forwardPE': -201.38298,
 'fromCurrency': None,
 'fullTimeEmployees': 670,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.04072,
 'heldPercentInstitutions': 0.55867,
 'industry': 'Health Information Services',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1153094400,
 'lastSplitFactor': '1:2',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/10xgenomics.com',
 'longBusinessSummary': '10x Genomics, Inc., a life science technology '
                        'company, develops and sells instruments, consumables, '
                        'and software for analyzing biological systems in '
                        'North America, Europe, the Middle East, Africa, '
                        'China, and the Asia Pacific. Its company offers '
                        'chromium instruments, enzymes, microfluidic chips, '
                        'slides, reagents, and other consumable products. The '
                        "company's single cell solution runs on its chromium "
                        'instruments, which include single cell gene '
                        'expression for measuring gene activity on a '
                        'cell-by-cell basis; single cell immune profiling for '
                        'measuring the activity of immune cells and their '
                        'targets; single cell ATAC for measuring epigenetics, '
                        'including the physical organization of DNA; single '
                        'cell CNV for measuring cellular heterogeneity through '
                        'DNA changes, such as copy number variation; and '
                        'visium spatial gene expression solution that measures '
                        'the spatial gene expression patterns across a tissue '
                        'sample. It serves various academic, government, '
                        'biopharmaceutical, biotechnology, and other '
                        'institutions. The company was formerly known as 10X '
                        'Technologies, Inc. and changed its name to 10X '
                        'Genomics, Inc. in November 2014. 10x Genomics, Inc. '
                        'was founded in 2012 and is headquartered in '
                        'Pleasanton, California.',
 'longName': '10x Genomics, Inc.',
 'market': 'us_market',
 'marketCap': 9309869056,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_223288117',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -48758000,
 'nextFiscalYearEnd': 1640908800,
 'open': 95.76,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 0.65,
 'phone': '925 401 7300',
 'previousClose': 95.85,
 'priceHint': 2,
 'priceToBook': 21.584948,
 'priceToSalesTrailing12Months': 35.235294,
 'profitMargins': -0.18452999,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 95.76,
 'regularMarketDayLow': 93.14,
 'regularMarketOpen': 95.76,
 'regularMarketPreviousClose': 95.85,
 'regularMarketPrice': 95.76,
 'regularMarketVolume': 427501,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 57934400,
 'sharesPercentSharesOut': 0.0279,
 'sharesShort': 2746470,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1800068,
 'shortName': '10x Genomics, Inc.',
 'shortPercentOfFloat': 0.049099997,
 'shortRatio': 2.26,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'TXG',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -5.407,
 'twoHundredDayAverage': 79.673454,
 'volume': 427501,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.10xgenomics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '94588'}